Approval Year
Substance Class |
Protein
Created
by
admin
on
Edited
Wed Apr 02 01:47:17 GMT 2025
by
admin
on
Wed Apr 02 01:47:17 GMT 2025
|
Protein Sub Type | |
Sequence Origin | HUMAN |
Sequence Type | COMPLETE |
Record UNII |
P93F057EMS
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
Q16236
Created by
admin on Wed Apr 02 01:47:17 GMT 2025 , Edited by admin on Wed Apr 02 01:47:17 GMT 2025
|
PRIMARY | |||
|
P93F057EMS
Created by
admin on Wed Apr 02 01:47:17 GMT 2025 , Edited by admin on Wed Apr 02 01:47:17 GMT 2025
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
INDUCER -> TARGET |
|
||
|
ACTIVATOR -> TARGET |
Bardoxolone methyl covalently binds to the reactive cysteine residue(s) of Keap1, releasing Nrf2 from the proteasome pathway into the nucleus.
|
||
|
ACTIVATOR -> TARGET |
|
||
|
ACTIVATOR -> TARGET |
Reacts with reactive cysteine residues through covalent, resulting in the conformational changes of Keap1 and the release of Nrf2 from Keap1.
|
||
|
ACTIVATOR -> TARGET |
Baicalein exerts its effects by inactivating Keap1 through interaction with the cysteine thiol residues of Keap1, subsequently inducing Nrf2 nuclear translocation.
|
||
|
ACTIVATOR -> TARGET |
|
||
|
ACTIVATOR -> TARGET |
|
||
|
INHIBITOR -> TARGET |
|
||
|
ACTIVATOR -> TARGET |
|
||
|
ACTIVATOR -> TARGET |
|
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Molecular Formula | CHEMICAL |
|
||||
MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|